These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 19226374)

  • 1. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.
    Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A
    J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
    Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolism of the ischemic myocardium in non-insulin-dependent diabetes].
    Uccella R
    Minerva Med; 1989 Sep; 80(9):965-8. PubMed ID: 2812481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial metabolism during the pre-ischemic administration of metabolic myocardial protection in coronary surgical patients].
    Zwölfer W; Hiesmayr M; Holzinger C; Perger P; Coraim F; Haider W
    Anaesthesist; 1990 Oct; 39(10):481-6. PubMed ID: 2278366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
    Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
    Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism in non-diabetic patients with stable coronary artery disease.
    Santos JF; Almeida M; Ferreira J; Gonçalves P; Raposo L; Teles R; Branco J; Catroga T; Machado FP; Silva A
    Rev Port Cardiol; 2006 Jan; 25(1):39-53. PubMed ID: 16623355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.
    Tuttle KR; Puhlman ME; Cooney SK; Short R
    Am J Kidney Dis; 1999 Nov; 34(5):918-25. PubMed ID: 10561150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic severity and morphological spectrum of coronary artery disease in non insulin dependent diabetes mellitus.
    Calton R; Calton R; Dhanoa J; Jaison TM
    Indian Heart J; 1995; 47(4):343-8. PubMed ID: 8557276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
    Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
    Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
    Wang G; Wei J; Guan Y; Jin N; Mao J; Wang X
    Metabolism; 2005 May; 54(5):590-7. PubMed ID: 15877288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
    Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.